NDC 66689-028-01 - Levetiracetam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66689-028
- Requested NDC
- 66689-028-01
- Package NDCs from labels
- 66689-028-01, 66689-028-50
- Manufacturer
- VistaPharm, LLC
- Effective date
- 2022-11-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levetiracetam - VistaPharm, LLC | VistaPharm, LLC | 2022-11-30 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 66689-028-01 | ML - Milliliter | 66689-028 | 54873b8a-90c5-453e-bc14-4ce23bc212d2 | 1 | 2012-07-24 |
| 66689-028-50 | ML - Milliliter | 66689-028 | a8c7728e-1bbd-4637-9c28-3865ce4ee85e | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Refresh Optive Mega-3 PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | 326cb5d6-c784-404f-9a13-6d69262dda6e | 2026-03-01 | Warnings | PDC6A3C0OX |
| Dermatool Hemorrhoidal | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Papalo Group LLC | 4bc06f41-7733-ebd0-e063-6294a90af7a8 | 2026-02-26 | Warnings | PDC6A3C0OX |
| Tricitrates | TRICITRATES | Chartwell Governmental & Specialty RX, LLC. | c4ff0407-3930-4c48-afd4-d2cb3e1b18f4 | 2026-02-25 | Warnings, Adverse reactions | 2968PHW8QP |
| Potassium Citrate and Citric Acid | POTASSIUM CITRATE AND CITRIC ACID | Chartwell Governmental & Specialty RX, LLC. | fd57a176-7faf-4053-b348-6ba5f192f05a | 2026-02-25 | Warnings, Adverse reactions | 2968PHW8QP |
| WowDay Hemorrhoid and Fissure Cream | HEMORRHOID AND FISSURE CREAM | WowDay LLC | 47ba86ad-240a-e733-e063-6394a90a24e3 | 2026-02-12 | Warnings | PDC6A3C0OX |
| Viva Hydration Boost | GLYCERIN | Nomax Inc | 174193b2-65eb-b5fd-e063-6394a90a9cd0 | 2026-02-10 | Warnings | PDC6A3C0OX |
| Levetiracetam | LEVETIRACETAM | Fresenius Kabi USA, LLC | da858849-1d18-4d38-b53d-d4dd1cd8fabc | 2026-02-05 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | A-S Medication Solutions | 30f43d3b-c944-4f25-b5d3-009294944962 | 2026-02-02 | Warnings, Adverse reactions | 44YRR34555 |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Additive Formula 3 | DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, AND ADENINE | Terumo BCT, Ltd | 9a5247a1-cc05-442d-b2d0-950f887f03c2 | 2026-01-30 | Warnings, Adverse reactions | 2968PHW8QP B22547B95K |
| Regener-Eyes Ophthalmic Solution LITE XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 47ab9609-4291-30b2-e063-6394a90a421e | 2026-01-29 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution PROFESSIONAL STRENGTH XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 48d6dc98-66e8-b499-e063-6394a90ae935 | 2026-01-29 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-01-29 | Warnings | PDC6A3C0OX |
| Keppra | LEVETIRACETAM | UCB, Inc. | 3ca9df05-a506-4ec8-a4fe-320f1219ab21 | 2026-01-28 | Warnings, Adverse reactions | 403884 44YRR34555 |
| Regener-Eyes Ophthalmic Solution PROFESSIONAL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, LLC | 49771efa-6682-51d0-e063-6294a90a18a5 | 2026-01-28 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution LITE | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, LLC | 497763ee-dc70-bb48-e063-6294a90afb3d | 2026-01-28 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.